The CMPDI IPO is attracting attention as it enters its second day. Discover key details including GMP, price band, and subscription status to guide your investment.
Indian pharmaceutical companies are launching affordable alternatives to Novo Nordisk’s Ozempic and Wegovy, expanding access to weight-loss medications.